Cardiovascular adverse events during treatment with darunavir-based regimens in an Italian observational study by Antinori A, Rusconi S, Gianotti N, Bini T, Mancusi D, Termini R

Get full text

Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines by Colombo GL, Matteo SD, Antinori A, Medaglia M, Murachelli S, Rizzardini G

Get full text

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatm... by Restelli U, Rizzardini G, Antinori A, Lazzarin A, Bonfanti M, Bonfanti P, Croce D

Get full text

Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. by Bhaskaran, K, Mussini, C, Antinori, A, Walker, A, Dorrucci, M, Sabin, C, Phillips, A, Porter, K

Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service by Restelli U, Andreoni M, Antinori A, Bonfanti M, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Croce D

Get full text

Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study by Antinori A, Meraviglia P, d’Arminio Monforte A, Castagna A, Mussini C, Bini T, Gianotti N, Rusconi S, Colella E, Airoldi G, Mancusi D, Termini R

Get full text

Identification of the minimal conserved structure of the HIV reverse transcriptase under the presence and absence of drug pressure by Ceccherini-Silberstein, F, Santoro, M, Svicher, V, Forbici, F, Gori, C, Esnouf, R, Ciccozzi, M, Alvarez, MR, D'Arrigo, R, Bellocchi, M, Balotta, C, Bertoli, A, Giannella, S, Cenci, A, Trotta, M, Balzarini, J, Monforte, A, Antinori, A, Perno, C

Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort by d'Arminio Monforte, A, Cozzi-Lepri, A, Ceccherini-Silberstein, F, De Luca, A, Lo Caputo, S, Castagna, A, Mussini, C, Cingolani, A, Tavelli, A, Shanyinde, M, Gori, A, Girardi, E, Andreoni, M, Antinori, A, Puoti, M, on behalf of Icona Foundation And Hepaicona Study Group

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study by Gregson, J, Tang, M, Ndembi, N, Hamers, R, Marconi, V, Brooks, K, Theys, K, Arruda, M, Garcia, F, Monge, S, Kanki, P, Kumarasamy, N, Kerschberger, B, Mor, O, Charpentier, C, Todesco, E, Rokx, C, Gras, L, Halvas, E, Sunpath, H, Carlo, D, Antinori, A, Andreoni, M, Latini, A, Mussini, C, Aghokeng, A, Sonnerborg, A, Neogi, U, Fessel, W, Agolory, S, Yang, C, Blanco, J, Juma, J, Smit, E, Schmidt, D, Watera, C, Asio, J, Kirungi, W, Tostevin, A, Clumeck, N, Goedhals, D, Bester, P, Sabin, C, Mukui, I, Santoro, M, Perno, C, Hunt, G, Morris, L, Camacho, R, Pillay, D, Schulter, E, Reyes-Terán, G, Romero, K, Avila-Rios, S, Sirivichayakul, S, Ruxrungtham, K, Mekprasan, S, Dunn, D, Kaleebu, P, Raizes, E, Kantor, R, Shafer, R, Gupta, R, Rhee, S, De Wit, T, Diero, L, Günthard, H, Hoffmann, C, Di Carlo, D